These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 86376)

  • 1. Precision in estimating gestational age and its influence on sensitivity of alphafetoprotein screening.
    Roberts CJ; Hibbard BM; Evans DR; Evans KT; Laurence KM; Hoole M; Roberts E; Ennis WP
    Br Med J; 1979 Apr; 1(6169):981-3. PubMed ID: 86376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of estimating gestational age by ultrasound cephalometry on the specificity of alpha-fetoprotein screening for open neural-tube defects.
    Wald N; Cuckle H; Boreham J; Turnbull AC
    Br J Obstet Gynaecol; 1982 Dec; 89(12):1050-3. PubMed ID: 6184069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of accurate gestational age estimation in screening for fetal neural tube defects using maternal serum alpha-fetoprotein levels.
    Kirkpatrick A; Cohen M; Prescott GH; Jones OW; Matson M; Wepsic HT
    UCLA Forum Med Sci; 1978; 20():199-205. PubMed ID: 80862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for fetal malformations using ultrasound and measurements of alpha-fetoprotein in maternal serum.
    Persson PH; Kullander S; Gennser G; Grennert L; Laurell CB
    Br Med J (Clin Res Ed); 1983 Mar; 286(6367):747-9. PubMed ID: 6186332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antenatal screening for neural tube defect by measuring alphafetoprotein in dried blood eluates (author's transl)].
    Augier D; Dutau G; Petrus M; Grandjean H; Pontonnier G; Rochiccioli P
    Arch Fr Pediatr; 1981 Dec; 38(10):757-60. PubMed ID: 6174100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-fetoprotein detection of neural tube defects and the impact of standard ultrasound.
    Dashe JS; Twickler DM; Santos-Ramos R; McIntire DD; Ramus RM
    Am J Obstet Gynecol; 2006 Dec; 195(6):1623-8. PubMed ID: 16769022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal serum alpha-fetoprotein screening for the detection of neural tube defects.
    Crandall BF; Robertson RD; Lebherz TB; King W; Schroth PC
    West J Med; 1983 Apr; 138(4):524-30. PubMed ID: 6191442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Dual positivity' for neural tube defects and down syndrome at maternal serum screening: gestational outcome.
    Zanini R; Tarantini M; Cerri V; Jacobello C; Bellotti D; Lancetti S; Scalchi S; Groli C; Bianchi UA
    Fetal Diagn Ther; 1998; 13(2):106-10. PubMed ID: 9650657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal diagnosis of neural tube defects. VIII. The importance of serum alpha-fetoprotein screening in diabetic pregnant women.
    Milunsky A; Alpert E; Kitzmiller JL; Younger MD; Neff RK
    Am J Obstet Gynecol; 1982 Apr; 142(8):1030-2. PubMed ID: 6176126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity of amniotic fluid alpha-fetoprotein with concanavallin A in diagnosis of neural tube defects.
    Smith CJ; Kelleher PC; Bélanger L; Dallaire L
    Br Med J; 1979 Apr; 1(6168):920-1. PubMed ID: 86375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural-tube defect risk assessment for individual pregnancies using alphafetoprotein and acetylcholinesterase test results.
    Strike PW; Smith J
    J Clin Pathol; 1982 Dec; 35(12):1334-9. PubMed ID: 6184385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk assessment adjusted for gestational age in maternal serum screening for Down's syndrome.
    Gardosi J; Mongelli M
    BMJ; 1993 Jun; 306(6891):1509-11. PubMed ID: 8518678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prenatal detection of open neural tube defects in a mass screening program by determination of alpha-fetoprotein concentration in maternal serum].
    Zwahr C; Körner H; Tinschert S; Horn A; Schulze M; Voigt M
    Zentralbl Gynakol; 1988; 110(3):158-67. PubMed ID: 2452529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gestational age assessment by nurses in a developing country using the Ballard method, external criteria only.
    Verhoeff FH; Milligan P; Brabin BJ; Mlanga S; Nakoma V
    Ann Trop Paediatr; 1997 Dec; 17(4):333-42. PubMed ID: 9578793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal detection of neural tube defects by maternal serum alphafetoprotein assay.
    Grace HJ; Gray R; Conradie JD
    S Afr Med J; 1981 Aug; 60(8):319-24. PubMed ID: 6166994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compromise ultrasound dating policy in maternal serum screening for Down syndrome.
    Rahim RR; Cuckle HS; Sehmi IK; Jones RG
    Prenat Diagn; 2002 Dec; 22(13):1181-4. PubMed ID: 12478629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High maternal serum alpha-fetoprotein and low birthweight. A study concerning possible correlation between maternal weight, smoking, and serum alpha-fetoprotein and subsequent birthweight and gestational age.
    Secher NJ; Eriksen PS; Hansen PK; Lenstrup C; Thisted J
    Am J Perinatol; 1985 Apr; 2(2):78-81. PubMed ID: 2420339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal diagnosis, fetal surgery, recurrence risk and differential diagnosis of neural tube defects.
    Chen CP
    Taiwan J Obstet Gynecol; 2008 Sep; 47(3):283-90. PubMed ID: 18935990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.